Browse Cancer research topic

Patient outcomes subtopic

Articles 1-51 out of 51 article(s) Title Author Type Date Words Anti-Estrogens Offer Protection against Lung Cancer Mortality. Dec 14, 2009 285 Vitamin D levels linked to survival in lymphoma patients. Dec 6, 2009 314 BSD Medical Reports Hyperthermia Therapy Contributes to Improved Survival Rate for Bladder Cancer Patients. Oct 30, 2009 683 BSD Medical Reports News Briefing at Europe's Largest Cancer Congress: Hyperthermia and Chemotherapy Treatment Prolongs Survival of Sarcoma Cancer Patients. Sep 22, 2009 660 New Data from Phase III SATURN Study Showed Tarceva Extended Survival in Patients with Advanced Non-Small Cell Lung Cancer When Used Immediately after Initial Chemotherapy. Clinical report Aug 1, 2009 1436 Cancer vaccines lead to long-term survival for skin cancer patients. Jul 29, 2009 419 HPV STATUS PREDICTS SURVIVAL IN OROPHARYNGEAL CANCERS. Clinical report Jul 1, 2009 817 Fury over Britain's 15,000 'needless' deaths from cancer. Jun 26, 2009 601 Study: transplant patients have worse outcomes from cancer. Jun 1, 2009 230 Metastatic Colon Cancer: In a Randomized Phase II Clinical Study, Antineoplaston Therapy Doubled the 5-Year Survival Rate Following Curative Resection of Hepatic Metastases. Clinical report May 27, 2009 490 Clinical Data, Inc. and Dana-Farber Cancer Institute Form Research Collaboration to Study Role of FCGR3A Gene Variants for Predicting Clinical Outcomes in Breast Cancer Treatment. May 18, 2009 1303 Chemotherapy helps lift cancer surgery survival; Treatment cuts death rate by 30%, say city scientists. Jan 20, 2009 430 Family history of prostate cancer does not affect outcomes of seed implant therapy. Jan 5, 2009 307 Obesity has no major impact on ovarian cancer survival: Study. Dec 30, 2008 263 Behavioral activation therapy for depressed cancer patients: factors associated with treatment outcome and attrition. Hopko, D.R.; Robertson, S.M.C.; Colman, L. Dec 22, 2008 5610 Clinical Data, Inc. Establishes Research Collaboration to Confirm Role of FCGR3A Pathway for Predicting Clinical Outcomes in Breast Cancer Treatment. Dec 11, 2008 1222 Psychological interventions may improve survival in breast cancer patients. Dec 3, 2008 272 Psychological interventions may improve survival in breast cancer patients. Nov 25, 2008 272 ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced. Aug 29, 2008 2114 ADVEXIN(R) Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population. Jul 23, 2008 1232 CANCER SURVIVAL RATES TRANSFORMED BY NHS; Chance of life doubled in 60 years. Jul 3, 2008 471 QoL, cancer outcome linked in meta-analyses. Wachter, Kerri Clinical report Jul 1, 2008 974 Study Suggests Survival Benefit from Radioactive Microsphere Therapy in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy. Clinical report Jun 2, 2008 1087 VIDAZA Data Presented at ASCO Demonstrates Significant Overall Survival for Myelodysplastic Syndrome Patients. Clinical report Jun 2, 2008 537 RTOG Study: Adding Cetuximab to Chemotherapy and Radiotherapy Leads to Improved Outcome for Lung Cancer Patients. Clinical report May 31, 2008 2392 DNA Modification Seen in Colorectal Tumors Helps Predict Outcomes, John Wayne Cancer Institute Researchers Find. May 21, 2008 702 ASTRO's Official Journal Publishes 12-Year Survival Data Following Landmark Study of Cancer Treatment with Hyperthermia Therapy. Clinical report Apr 2, 2008 753 Expression Pathology Aids Research in Identifying Biomarkers of Lung Cancer Metastasis and Survival. Disease/Disorder overview Feb 19, 2008 353 AVADO Study of Avastin Plus Docetaxel Chemotherapy Showed Improved Progression-Free Survival in Patients with Advanced Breast Cancer. Clinical report Feb 12, 2008 1090 BSD Medical Reports Upcoming Publication of 12-Year Cancer Survival Data Following Landmark Study of Hyperthermia Therapy. Clinical report Sep 27, 2007 718 Britain is put to shame in cancer survival league; Let down: UK women have the lowest cancer survival rates in Western Europe. Aug 21, 2007 667 Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer. Clinical report Jun 4, 2007 1382 Single-Agent SUTENT Prolonged Progression-Free Survival across All Advanced Kidney Cancer Patient Risk Groups, Including Those with Poorest Prognoses, Data Show. Jun 3, 2007 1105 Outcomes Data Continue to Demonstrate Value of Cytogen's PROSTASCINT(R) to Predict Prognosis in Prostate Cancer. Clinical report May 22, 2007 1386 Cancer survival rate has doubled in three decades. May 15, 2007 558 Cancer survival rate has doubled in three decades. May 15, 2007 561 OSI Pharmaceuticals Announces Pivotal Phase III Tarceva(R) Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer. Apr 25, 2007 989 Aranesp(R) "145 Study" Shows No Difference in Survival in Patients with Small-Cell Lung Cancer. Clinical report Apr 19, 2007 1905 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients. Clinical report Apr 16, 2007 2452 Aspect Medical Systems Sponsors Cleveland Clinic Studies to Investigate Impact of Anesthetic Management Techniques on Patient Outcomes. Mar 27, 2007 1149 Seven-Year Survival Data Demonstrate use of Cytogen's PROSTASCINT(R) Independently Predicts Recurrence of Prostate Cancer. Feb 8, 2007 1263 15-Year Study of More Than 5,000 Patients Reveals Key Factors in Predicting Outcomes for Prostate Cancer Recurrence Following Permanent Prostate Brachytherapy. Dec 4, 2006 792 Clinical Cancer Research Publishes Paper Comparing CTCs to Imaging in Predicting Overall Survival in Metastatic Breast Cancer. Nov 7, 2006 1001 Landmark Study Involving United Steelworkers Reveals That Lung Cancer 10-Year Survival Dramatically Improves With Annual CT Screening and Prompt Treatment. Oct 31, 2006 646 Further Analysis of Phase III Data Using CALGB and EORTC Paradigms Reinforces Survival Benefits of ONCONASE(R) for the Treatment of Patients with Mesothelioma. Clinical report Oct 24, 2006 973 How ginseng could be the root to survival. Mar 31, 2006 332 New Biotechnology Company Forms and Announces Plan; Asuragen Targets Early Diagnosis and Treatment Outcome for Cancer Patients with Key Molecular Diagnostics Research. Jan 6, 2006 732 More Accurate, Quantitative Method Reported for Linking Biomarker Expression to Patient Outcomes. Dec 21, 2005 1017 BREAST CANCER SURVIVAL BOOST. Dec 16, 2005 191 ERBITUX(R) Data on Locoregional Control and Overall Survival in Phase III Head and Neck Cancer Study Presented at AACR-NCI-EORTC Meeting. Nov 16, 2005 1487 Clofarabine's Duration of Response Improves Outcome for Elderly AML Patients. Nov 9, 2005 927